Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6866)
All Articles published online
|
Publishing Process of This Article
|
Jan 14, 2015 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Hou KZ, Fu ZQ, Gong H. Chemokine ligand 20 enhances progression of hepatocellular carcinoma |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i2/475.htm |
| Number | Citing Articles |
| 1 |
Manzoor Ahmad Mir, Aanisa Ishrat, Nusrat Jan. Cytokine and Chemokine Networks in Cancer. 2023; : 353 doi: 10.1007/978-981-99-4657-0_13
|
| 2 |
Nicolas Goffart, Arnaud Lombard, François Lallemand, Jérôme Kroonen, Jessica Nassen, Emmanuel Di Valentin, Sharon Berendsen, Matthias Dedobbeleer, Estelle Willems, Pierre Robe, Vincent Bours, Didier Martin, Philippe Martinive, Pierre Maquet, Bernard Rogister. CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone. Neuro-Oncology 2017; 19(1): 66 doi: 10.1093/neuonc/now136
|
| 3 |
Jiatai Zhang, Chenyang Zhao, Tengteng Hu, Jipeng Yang, Qian Wu, Cheng Wang, Shuying Dong. The role of PI3K/AKT-related proteins in di(2-ethyl)hexylphthalate-induced BG-1 and MCF-7 cell proliferation, and inhibition by metformin. Immunopharmacology and Immunotoxicology 2023; 45(3): 378 doi: 10.1080/08923973.2022.2151915
|
| 4 |
Gui-Zhen Wang, Xin Cheng, Xin-Chun Li, Yong-Qiang Liu, Xian-Quan Wang, Xu Shi, Zai-Yong Wang, Yong-Qing Guo, Zhe-Sheng Wen, Yun-Chao Huang, Guang-Biao Zhou. Tobacco smoke induces production of chemokine CCL20 to promote lung cancer. Cancer Letters 2015; 363(1): 60 doi: 10.1016/j.canlet.2015.04.005
|
| 5 |
WEI-LU WU, WEI-YA WANG, WEN-QING YAO, GAN-DI LI. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. International Journal of Molecular Medicine 2015; 36(6): 1713 doi: 10.3892/ijmm.2015.2379
|
| 6 |
Hongwu Tan, Shuyun Wang, Ludong Zhao. A tumour‐promoting role of Th9 cells in hepatocellular carcinoma through CCL20 and STAT3 pathways. Clinical and Experimental Pharmacology and Physiology 2017; 44(2): 213 doi: 10.1111/1440-1681.12689
|
| 7 |
Mitsuro Kanda, Hiroyuki Sugimoto, Yasuhiro Kodera. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(37): 10584-10597 doi: 10.3748/wjg.v21.i37.10584
|
| 8 |
Wei Chen, Jing Zhang, Hui-Ning Fan, Jin-Shui Zhu. Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease. Therapeutic Advances in Gastroenterology 2018; 11: 175628481881518 doi: 10.1177/1756284818815184
|
| 9 |
Xiongfeng Pan, Atipatsa Chiwanda Kaminga, Aizhong Liu, Shi Wu Wen, Jihua Chen, Jiayou Luo. Chemokines in Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01802
|
| 10 |
Hiroji Shinkawa, Shogo Tanaka, Daijiro Kabata, Shigekazu Takemura, Ryosuke Amano, Kenjiro Kimura, Masahiko Kinoshita, Shoji Kubo. The Prognostic Impact of Tumor Differentiation on Recurrence and Survival after Resection of Hepatocellular Carcinoma Is Dependent on Tumor Size. Liver Cancer 2021; 10(5): 461 doi: 10.1159/000517992
|
| 11 |
Huiqiang Wang, Bin Chen, Bo Duan, Jiaxin Zheng, Xinyi Wu. miR-205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma. Molecular Medicine Reports 2016; 14(4): 3343 doi: 10.3892/mmr.2016.5589
|
| 12 |
Julia Odenthal, Robert Takes, Peter Friedl. Plasticity of tumor cell invasion: governance by growth factors and cytokines. Carcinogenesis 2016; : bgw098 doi: 10.1093/carcin/bgw098
|
| 13 |
Zheng Wang, Jie Zhu, Yongjuan Liu, Changhong Liu, Wenqi Wang, Fengzhe Chen, Lixian Ma. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02255-6
|
| 14 |
Dario Gregori. Reply to Are Worries and Concerns Information Side Effects?. Inflammatory Bowel Diseases 2015; 21(9): E23 doi: 10.1097/MIB.0000000000000555
|
| 15 |
Yan‐Ming Xu, Yang‐Min Gao, Dan‐Dan Wu, Fei‐Yuan Yu, Zhong‐Sheng Zang, Lei Yang, Yue Yao, Na‐Li Cai, Yuan Zhou, Jen‐Fu Chiu, Yick‐Pang Ching, Andy T. Y. Lau. Aberrant cytokine secretion and zinc uptake in chronic cadmium‐exposed lung epithelial cells. PROTEOMICS – Clinical Applications 2017; 11(3-4) doi: 10.1002/prca.201600059
|
| 16 |
Lin Du, Manli Wang, Hui Li, Na Li, Fang Wang, Jie Mei. Identification of CCL20 and LCN2 as Efficient Serological Tools for Detection of Hepatocellular Carcinoma. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/7758735
|
| 17 |
Gang Han, Dawei Wu, Yongan Yang, Zhiyun Li, Jiapin Zhang, Chengjun Li. CrkL meditates CCL20/CCR6-induced EMT in gastric cancer. Cytokine 2015; 76(2): 163 doi: 10.1016/j.cyto.2015.05.009
|
| 18 |
Ha Thi Thu Do, Chang Hoon Lee, Jungsook Cho. Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers. Cancers 2020; 12(2): 287 doi: 10.3390/cancers12020287
|
| 19 |
Josef Ehling, Frank Tacke. Role of chemokine pathways in hepatobiliary cancer. Cancer Letters 2016; 379(2): 173 doi: 10.1016/j.canlet.2015.06.017
|
| 20 |
Monika Zajkowska, Barbara Mroczko. Chemokines in Primary Liver Cancer. International Journal of Molecular Sciences 2022; 23(16): 8846 doi: 10.3390/ijms23168846
|
| 21 |
Amber M. Kennon, James A. Stewart. Paracrine Signals in Calcified Conditioned Media Elicited Differential Responses in Primary Aortic Vascular Smooth Muscle Cells and in Adventitial Fibroblasts. International Journal of Molecular Sciences 2023; 24(4): 3599 doi: 10.3390/ijms24043599
|
| 22 |
Wanmi Sui, Weijia Wang. Bufalin Suppresses Colorectal Cancer Cells by the Blockade of Canonical Wnt Signaling Pathway. 2022 4th International Conference on Intelligent Medicine and Image Processing 2022; : 8 doi: 10.1145/3524086.3524088
|
| 23 |
Sugandha Saxena, Rakesh K. Singh. Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity. Cancer and Metastasis Reviews 2021; 40(2): 447 doi: 10.1007/s10555-021-09970-6
|
| 24 |
Jan Korbecki, Szymon Grochans, Izabela Gutowska, Katarzyna Barczak, Irena Baranowska-Bosiacka. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands. International Journal of Molecular Sciences 2020; 21(20): 7619 doi: 10.3390/ijms21207619
|
| 25 |
Amanda Hanson, Ignazio S. Piras, Danielle Wilhelmsen, Christopher D. Still, Xin Chu, Anthony Petrick, Glenn S. Gerhard, Johanna K. DiStefano. Chemokine ligand 20 (CCL20) expression increases with NAFLD stage and hepatic stellate cell activation and is regulated by miR-590-5p. Cytokine 2019; 123: 154789 doi: 10.1016/j.cyto.2019.154789
|
| 26 |
Xiaolei Jiao, Guiming Shu, Hui Liu, Qin Zhang, Zhe Ma, Chaoyi Ren, Hongsheng Guo, Jingxiang Shi, Junguo Liu, Chuanshan Zhang, Yijun Wang, Yingtang Gao. The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis. Journal of Histochemistry & Cytochemistry 2019; 67(5): 299 doi: 10.1369/0022155418824274
|
| 27 |
Tao Chen, Jufeng Guo, Zhenhai Cai, Binghao Li, Lingling Sun, Yingying Shen, Shengdong Wang, Zhan Wang, Zenan Wang, Yucheng Wang, Hao Zhou, Zhijian Cai, Zhaoming Ye. Th9 Cell Differentiation and Its Dual Effects in Tumor Development. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01026
|
| 28 |
JI QIN GAI, XIA SHENG, JIAN MIN QIN, KANG SUN, WEI ZHAO, LEI NI. The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt/β-catenin signaling pathway. International Journal of Oncology 2016; 48(1): 338 doi: 10.3892/ijo.2015.3250
|
| 29 |
Mohammed Benkheil, Matthias Van Haele, Tania Roskams, Manon Laporte, Sam Noppen, Kayvan Abbasi, Leen Delang, Johan Neyts, Sandra Liekens. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer. Experimental Cell Research 2018; 372(2): 168 doi: 10.1016/j.yexcr.2018.09.023
|